Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Aslam M. Khaja"'
Autor:
Rima M. Dafer, James Conners, Gabriela Trifan, Parneet Grewal, Eric M. Liotta, Shyam Prabhakaran, Fan Z. Caprio, Fernando D. Goldenberg, Michael J. Schneck, Alejandro Vargas, James R. Brorson, Philip B. Gorelick, Sean Ruland, Faddi Ghassan Saleh Velez, Neelofer Shafi, W. Taylor, R. A. Dyer, José Biller, Julianne P. Hall, I. DaSilva, L. Chirstos, Pranusha Pinna, Michael Teitcher, Bayan Moustafa, Aslam M. Khaja, Ayush Batra, Zachary Bulwa, Nicholas Osteraas, Fernando D. Testai, Nicholas J. Reish, P. de la Pena, Sayona John, Kristin L. Miller, T. Terna
Publikováno v:
Stroke. 52
Background: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection is associated with stroke. The role of sex on stroke outcome has not been investigated. We describe the characteristics of a diverse cohort of acute stroke patients wi
Autor:
José Biller, Christos Lazaridis, Parneet Grewal, Kristin L. Miller, James Conners, R. Alvarado Dyer, F. G. Saleh Velez, T. Terna, Pranusha Pinna, Shyam Prabhakaran, Michael Teitcher, Nicholas Osteraas, Aslam M. Khaja, Zachary Bulwa, Rima M. Dafer, I. DaSilva, Nicholas J. Reish, Ayush Batra, Eric M. Liotta, Gabriela Trifan, Fan Z. Caprio, Fernando D. Goldenberg, Michael J. Schneck, Alejandro Vargas, Sayona John, Philip B. Gorelick, Neelofer Shafi, James R. Brorson, William F. Taylor, Fernando D. Testai, Julianne P. Hall, P. de la Pena, Bayan Moustafa, Sean Ruland
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases
Highlights • COVID-19 disease is associated with stroke • All strokes subtypes are seen in association with COVID-19, with ischemic stroke being most prevalent • The most common etiology for ischemic stroke in SARS-CoV2 infection is cryptogenic
The Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 Hours
Autor:
Hen Hallevi, James C. Grotta, Miguel A. Escobar, Teresa A. Allison, Andrew D Barreto, Aslam M. Khaja, Karen C. Albright, Hashem Shaltoni, Elizabeth A. Noser, Nicole R. Gonzales, Sheryl Martin-Schild, Kachi Illoh
Publikováno v:
Stroke. 39:473-475
Background and Purpose— Recombinant-activated factor VII (rFVIIa) is an investigational treatment for intracerebral hemorrhage (ICH). We have evaluated the drug’s treatment effect based on time to treatment. Methods— ICH patients treated up to
Autor:
Aslam M Khaja, Sandra L Hoelzel, Neelofer Shafi, Rebbeca Grysiewicz, Fernando D Testai, Jeffrey B Gordon, Sean Ruland
Publikováno v:
Stroke. 44
Background: Telestroke is a promising avenue for treatment of acute stroke patients when a vascular neurologist is not available for bedside assessment. We provide stroke hospitalist services at a local community hospital Monday-Friday, supplemented
Autor:
Rebbeca Grysiewicz, Jonathan Garoza, Shu B Chan, Aslam M Khaja, Sandra Hoelzel, Neelofer Shafi, Fernando Testai, Jeffrey Gordon, Sean Ruland
Publikováno v:
Stroke. 44
Background: It is estimated that only 1-3% of ischemic stroke patients receive IV r-tPA. There are multiple reported barriers that impede the administration of IV-tPA in ischemic stroke patients. However, one specific barrier continually cited by eme
Autor:
Aslam M. Khaja
Publikováno v:
Comprehensive Cardiovascular Medicine in the Primary Care Setting ISBN: 9781603279628
Contemporary Cardiology ISBN: 9783319976211
Contemporary Cardiology ISBN: 9783319976211
Until relatively recently, ischemic stroke management was a classic example of “diagnose and adios.” Care of patients presenting to the hospital or clinic with symptoms of stroke consisted of aspirin followed by rehabilitation, with few disease-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7764f965d173bb16a54edb80abaabfcd
https://doi.org/10.1007/978-1-60327-963-5_19
https://doi.org/10.1007/978-1-60327-963-5_19
Autor:
Elizabeth B. Jones, Anitha T. Abraham, M. Rick Sline, James C. Grotta, Hen Hallevi, Andrew D Barreto, Miriam M. Morales, Sean I Savitz, Aslam M. Khaja, Sheryl Martin-Schild
Background: The drip-and-ship method of treating stroke patients may increase the use of tissue plasminogen activator (t-PA) in community hospitals. Objective: The safety and early outcomes of patients treated with t-PA for acute ischemic stroke (AIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a593e290f01edff5dbf2fa4bbcf9e8
https://europepmc.org/articles/PMC2891901/
https://europepmc.org/articles/PMC2891901/
Autor:
Aslam M. Khaja
Publikováno v:
Neurologic clinics. 26(4)
The pathophysiology of acute ischemic stroke involves occlusion of a cerebral artery; therefore, cerebral reperfusion is the primary goal of acute treatment. This article discusses established and emerging therapies for acute ischemic stroke. In addi
Autor:
Andrew D Barreto, James C. Grotta, Hen Hallevi, Sean I Savitz, Sheryl Martin-Schild, Hashem Shaltoni, Raymond U. Weir, Aslam M. Khaja, Karen C. Albright, Kachi Illoh, Nicole R. Gonzales, Morgan S. Campbell, Elizabeth A. Noser
Publikováno v:
Stroke. 39(12)
Background and Purpose— Studies have established a relation between recanalization and improved clinical outcome in acute ischemic stroke patients; however, intra-arterial clot size has not been routinely assessed. The aim of the study was to deter
Autor:
Aslam M. Khaja, Karen C. Albright, Andrew D Barreto, James C. Grotta, Sean I Savitz, Hen Hallevi, Sheryl Martin-Schild, Nicole R. Gonzales
Publikováno v:
Archives of Neurology. 65
Background Patients with acute ischemic stroke (AIS) commonly have elevated blood pressure (BP). Guidelines have recommended against treatment with intravenous tissue plasminogen activator (tPA) when aggressive measures such as continuous infusion wi